Bioscibex is a biotech hardware startup developing next-generation single-use bioreactors that simplify and automate cell culture. Our first product, Swingo, reduces the traditional 7-step cell culture process to just 2 steps, lowering contamination risk, manual handling, and CapEx. With a working volume range of 30 mL to 30 L (expandable), it supports R&D to manufacturing applications. We partner with contract manufacturers to scale efficiently, while retaining customer engagement. Backed by CHF 1M in funding and early interest from major biopharma players, Bioscibex is preparing for a commercial launch in Q2 2026.
11.04.2025
Tech innovators of tomorrow face off at Startup Champions Seed Night 2025 (venturelab.swiss)
No milestones
No Jobs
No videos and documents
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.bioscibex.com
Headquarter:
Monthey
Foundation Date:
December 2024
Technology:
Sectors: